全球血管内动脉瘤修復设备市场规模（按产品类型、动脉瘤类型、最终用户、地区、范围和预测）

血管内动脉瘤修復设备的市场规模及预测

血管内动脉瘤修復设备市场规模预计在2023 年将达到26.47 亿美元，在2024 年至2030 年的预测期内以4.9% 的复合年增长率增长，到2030 年将达到43 亿美元。预计达到6000万美元。血管内动脉瘤修復设备市场包括各种专门设计用于微创治疗血管系统内动脉瘤的医疗设备和技术。这些装置用于血管内手术，修復血管的薄弱部分，降低破裂风险和可能危及生命的併发症。

血管内动脉瘤修復（EVAR）装置包括支架移植物、导管、导丝和其他相关工具，用于加固和稳定受影响的血管，而无需进行开放性手术。

血管内动脉瘤修復设备的全球市场驱动因子

血管内动脉瘤修復设备市场的市场推动因素可能受到多种因素的影响。

主动脉瘤的盛行率

推动全球 EVAR 设备市场发展的主要因素之一是主动脉瘤发生率的上升。由于生活方式的改变和人口老化，主动脉瘤，尤其是腹主动脉瘤 (AAA) 的发生率正在增加，因此需要有效的治疗方案。

技术开发：

随着血管内治疗技术和设备的技术发展，主动脉瘤的治疗选择正在不断扩大。由于支架移植物、输送方法和影像技术等技术创新，EVAR 手术的安全性和有效性正在提高，有助于推动市场扩张。

微创：

与开放手术相比，EVAR 手术具有创伤性较小、住院时间更短、恢復时间更快、发病率和死亡率更低等优点。患者和医生对微创手术的偏好日益增加，推动了 EVAR 的需求。

老年人口不断增加：

随着患者年龄的增长，他们更容易患主动脉瘤，对 EVAR 设备的需求也随之增加。全球人口老化，尤其是已开发国家人口老化，推动了对有效主动脉瘤治疗的需求，这有助于扩大市场。

政府措施与医疗改革：

EVAR 设备的采用是由政府旨在加强医疗保健系统和扩大获得尖端医疗服务机会的举措所推动的。鼓励血管内治疗的报销指南和医疗改革也推动了市场扩张。

宣传与筛检计画活动：

由于公众对主动脉瘤的认识以及透过筛检计画进行早期发现的价值不断提高，患者数量的增加和对 EVAR 治疗的需求正在推动市场扩张。

伙伴关係与合作关係：

透过与研究中心、医疗设备製造商和医疗保健提供者合作促进创新，我们开发了尖端的 EVAR 技术。策略合作伙伴关係还可以帮助我们利用互补的能力和资源来扩大市场。

在新兴市场扩张：

亚太、拉丁美洲、中东等新兴国家医疗基础建设发达、可支配收入不断上升、对前沿医疗的认知度不断提升，具有巨大的市场发展潜力。

限制全球血管内动脉瘤修復设备市场的因素

有几个因素可能会对血管内动脉瘤修復设备市场造成限製或课题。

EVAR 手术费用高：

考虑到设备、住院时间和术后护理，EVAR 手术的费用可能很高。 EVAR 的高成本可能会限制其使用，尤其是在医疗预算紧张或报销率低的地区。

长期耐用性问题：

儘管 EVAR 技术取得了进步，但关于长期可行性和潜在副作用（包括内漏、移植物移位和设备相关感染）的问题仍然存在。这些因素可能会影响患者的治疗结果，并阻止医生和患者选择 EVAR 而不是开放性手术。

缺乏熟练的介入医师：

进行 EVAR 治疗需要血管外科或介入放射学的特殊知识和训练。训练有素的干预人员的短缺，尤其是在偏远和贫困地区，可能会限制患者接受 EVAR 治疗并阻碍市场扩张。

监理课题与审批延迟：

EVAR 设备的监管审批是一个漫长而复杂的过程，涉及严格的临床试验和监管提交。获得新产品批准或对现有产品进行修改的延迟可能会阻碍市场进入和创新并减缓市场成长。

不良事件与再次介入的风险：

虽然内视镜静脉移植术（EVAR）治疗通常比开放性手术创伤性更小，但内漏、移植失败等问题始终存在。解决这些问题可能需要修復手术，这会增加医疗成本并对患者的生活品质产生负面影响。因此，患者可能不愿意接受 EVAR 治疗。

兑换范围有限：

某些医疗保健系统可能会透过严格的资格要求或报销政策来限制病患的就医机会，而这些保单不能完全涵盖 EVAR 手术的费用。报销不足可能会阻碍市场扩张，尤其是在自付费用较高的地区。

替代疗法：

主动脉瘤的替代疗法，例如开放式手术修復和影像监测随访，对于某些患者群体来说仍然适用。获得此类替代疗法可能会影响 EVAR 设备的采用和市场成长。

经济不确定性与市场波动：

投资选择和医疗保健支出可能会受到经济衰退、地缘政治不稳定和医疗保健政策变化带来的市场不确定性和波动的影响。市场动态可能会受到影响患者支付 EVAR 治疗费用的能力和医院采购决策的经济问题的影响。

目录

第 1 章简介

• 市场定义
• 市场区隔
• 研究方法

第 2 章执行摘要

• 主要发现 市场概况
• 市场亮点

第3章 市场概览

• 市场规模与成长潜力
• 市场趋势
• 市场推动因素
• 市场限制
• 市场机会
• 波特五力分析

第4章 血管内动脉瘤修復设备市场（依产品类型）

• 主动脉支架移植物
• 导管
• 导丝
• 血管内动脉瘤修復 (EVAR) 系统

第 5 章 血管内动脉瘤修復设备市场（按动脉瘤类型）

• 腹主动脉瘤 (AAA)
• 胸主动脉瘤 (TAA)
• 週边动脉瘤

第6章 血管内动脉瘤修復设备市场（依最终用户）

• 医院
• 门诊手术中心
• 专科诊所

第 7 章 区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利 亚太地区
• 中国
• 日本
• 印度
• 澳大利亚
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯联合大公国

第 8 章 市场动态

• 市场推动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第 9 章 竞争格局

• 大型公司
• 市占率分析

第10章 公司简介

• Medtronic plc
• Cook Medical Group
• Abbott Laboratories
• Becton, Dickinson and Company
• Cardinal Health Inc.
• Endologix, Inc.
• Lombard Medical Technologies plc
• Terumo Corporation
• W. L. Gore & Associates, Inc.
• Getinge AB

第 11 章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第 12 章附录

• 缩写列表
• 来源与参考文献

Endovascular Aneurysm Repair Devices Market Size And Forecast

Endovascular Aneurysm Repair Devices Market size was valued at USD 2647 Million in 2023 and is projected to reach USD 4360 Million by 2030 , growing at a CAGR of 4.9% during the forecast period 2024 to 2030. The Endovascular Aneurysm Repair Devices Market encompasses a range of medical devices and technologies designed for the minimally invasive treatment of aneurysms, particularly within the vascular system. These devices are utilized in endovascular procedures to repair weakened areas of blood vessels, thereby reducing the risk of rupture and potentially life-threatening complications.

Endovascular aneurysm repair (EVAR) devices include stent grafts, catheters, guidewires, and other related tools used to reinforce and stabilize the affected blood vessel without the need for open surgery.

Global Endovascular Aneurysm Repair Devices Market Drivers

The market drivers for the Endovascular Aneurysm Repair Devices Market can be influenced by various factors. These may include:

Prevalence of Aortic Aneurysms:

One major factor propelling the global market for EVAR devices is the rising incidence of aortic aneurysms. Effective treatment options are required since the incidence of aortic aneurysms, especially abdominal aortic aneurysms (AAA), is increasing due to changes in lifestyle and aging of the population.

Technological developments:

Technological developments in endovascular procedures and equipment have resulted in an expansion of treatment options for aortic aneurysms. The safety and effectiveness of EVAR operations have been enhanced by innovations like stent grafts, delivery methods, and imaging technologies, which have propelled market expansion.

Minimally Invasive Nature:

When EVAR procedures are performed instead of open surgery, they are less invasive and come with advantages like shorter hospital stays, quicker recovery times, and lower rates of morbidity and death. The demand for EVAR devices is being driven by patients' and doctors' increased preference for minimally invasive procedures.

Growing Senior Population:

As people age, they become more vulnerable to aortic aneurysms, which increases the need for EVAR devices. Growing worldwide, especially in developed nations, is the aging population, which raises the need for efficient aortic aneurysm treatment alternatives and propels market expansion.

Government Initiatives and Healthcare Reforms:

The adoption of EVAR devices is being driven by government initiatives aimed at enhancing the healthcare system and expanding access to cutting-edge medical treatments. Market expansion is also facilitated by reimbursement guidelines and healthcare reforms that encourage endovascular procedures.

Campaigns for Awareness and Screening Programs:

By driving up patient numbers and demand for EVAR treatments, initiatives to increase public knowledge of aortic aneurysms and the value of early detection through screening programs support market expansion.

Partnerships and Collaborations:

Research centers, medical device manufacturers, and healthcare providers work together to develop cutting-edge EVAR technology by promoting innovation. By utilizing complementary capabilities and resources, strategic partnerships also aid in market expansion.

Expansion in Emerging Markets:

Areas like Asia-Pacific, Latin America, and the Middle East offer substantial prospects for market growth due to the developing healthcare infrastructure in these countries, as well as rising disposable income and rising awareness of cutting-edge medical treatments.

Global Endovascular Aneurysm Repair Devices Market Restraints

Several factors can act as restraints or challenges for the Endovascular Aneurysm Repair Devices Market. These may include:

Exorbitant Cost of EVAR Procedures:

The price of EVAR procedures can be high, taking into account the devices, the hospital stay, and the aftercare. Because of its high cost, EVAR therapies may not be as widely available, especially in areas with tight healthcare budgets or low reimbursement.

Problems with Long-Term Sturdiness Concerns:

Although EVAR technology has advanced, questions still exist about its long-term viability and possible side effects such endoleaks, graft migration, and infections from the device. These elements may have an impact on patient outcomes and discourage doctors and patients from choosing EVAR over open surgery.

Scarce Skilled Interventionalists:

To execute EVAR treatments, one needs specific knowledge and training in either vascular surgery or interventional radiology. The scarcity of trained interventionists, especially in remote or underprivileged locations, can limit patient access to EVAR therapies and impede the expansion of the market.

Regulatory Difficulties and Approval Delays:

EVAR device regulatory approval can be obtained through a protracted and intricate process that includes stringent clinical trials and regulatory filings. Market entry and innovation might be hindered by delays in getting approvals for new products or modifications to current ones, which can slow down the growth of the market.

Risk of Adverse Events and Reinterventions:

Although endoscopic vein grafting (EVAR) treatments are typically less invasive than open surgery, there is always a chance of problems including endoleak or graft failure. Reinterventions may be necessary to address these issues, which could raise healthcare expenditures and negatively affect patient quality of life. As a result, patients may be reluctant to use EVAR treatments.

Limited Reimbursement Coverage:

In certain healthcare systems, patient access may be restricted by rigorous eligibility requirements or by reimbursement policies that do not sufficiently cover the expenses of EVAR procedures. Market expansion may be hampered by inadequate reimbursement, especially in areas where out-of-pocket costs are high.

Alternative Therapies:

For some patient populations, alternative therapies for aortic aneurysms, such as open surgical repair or watchful waiting along with imaging surveillance, are still appropriate. These substitutes' accessibility may have an impact on EVAR device adoption as well as market expansion.

Economic Uncertainty and Market Volatility:

Investment choices and healthcare spending can be impacted by market uncertainty and volatility brought about by economic downturns, geopolitical unrest, and changes in healthcare policy. Market dynamics may be impacted by economic issues that affect patients' ability to pay for EVAR treatments and hospitals' purchasing decisions.

Global Endovascular Aneurysm Repair Devices Market Segmentation Analysis

The Global Endovascular Aneurysm Repair Devices Market is segmented based on Product Type, Aneurysm Type, End User And Geography.

Endovascular Aneurysm Repair Devices Market, By Product Type

• Aortic Stent Grafts:
• Stent grafts designed specifically for the endovascular repair of aortic aneurysms, providing a minimally invasive alternative to open surgery.
• Catheters:
• Flexible tubes used for various diagnostic and interventional procedures, including guiding other medical devices such as stent grafts during endovascular aneurysm repair.
• Guidewires:
• Thin, flexible wires used to guide catheters and other medical devices through the blood vessels to reach the treatment site accurately.
• Endovascular Aneurysm Repair (EVAR) Systems:
• Comprehensive systems including devices such as stent grafts, catheters, and guidewires, designed to facilitate the minimally invasive repair of aortic aneurysms.

Endovascular Aneurysm Repair Devices Market, By Aneurysm Type

• Abdominal Aortic Aneurysms (AAA):
• Aneurysms occurring in the abdominal portion of the aorta, which can be treated using various endovascular techniques.
• Thoracic Aortic Aneurysms (TAA):
• Aneurysms affecting the thoracic portion of the aorta, often requiring specialized stent grafts for endovascular repair.
• Peripheral Aneurysms:
• Aneurysms found in peripheral arteries outside of the aorta, requiring tailored endovascular approaches for treatment.

Endovascular Aneurysm Repair Devices Market, By End User

• Hospitals:
• Facilities equipped with the infrastructure and expertise to provide comprehensive medical care, including the diagnosis and treatment of aortic aneurysms using endovascular devices.
• Ambulatory Surgical Centers:
• Outpatient facilities specializing in performing surgical procedures, including minimally invasive endovascular aneurysm repair, with shorter recovery times compared to traditional hospitals.
• Specialty Clinics:
• Clinics focusing on specific medical specialties, such as vascular surgery or interventional radiology, providing targeted care for patients requiring endovascular treatment for aneurysms.

Endovascular Aneurysm Repair Devices Market, By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Key Players

• The major players in the Endovascular Aneurysm Repair Devices Market are:
• Medtronic plc
• Cook Medical Group
• Abbott Laboratories
• Becton Dickinson and Company
• Cardinal Health Inc.
• Endologix Inc.
• Lombard Medical Technologies plc
• Terumo Corporation
• L. Gore & Associates Inc.
• Getinge AB

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Endovascular Aneurysm Repair Devices Market, By Product Type

• Aortic Stent Grafts
• Catheters
• Guidewires
• Endovascular Aneurysm Repair (EVAR) Systems

5. Endovascular Aneurysm Repair Devices Market, By Aneurysm Type

• Abdominal Aortic Aneurysms (AAA)
• Thoracic Aortic Aneurysms (TAA)
• Peripheral Aneurysms

6. Endovascular Aneurysm Repair Devices Market, By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Medtronic plc
• Cook Medical Group
• Abbott Laboratories
• Becton, Dickinson and Company
• Cardinal Health Inc.
• Endologix, Inc.
• Lombard Medical Technologies plc
• Terumo Corporation
• W. L. Gore & Associates, Inc.
• Getinge AB

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References